Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis

ClinicalTrials.gov ID: NCT03680131

Public ClinicalTrials.gov record NCT03680131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis

Study identification

NCT ID
NCT03680131
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Edesa Biotech Inc.
Industry
Enrollment
211 participants

Conditions and interventions

Interventions

  • EB01 Cream Placebo Drug
  • EB01 Cream 0.2% Drug
  • EB01 Cream 1.0% Drug
  • EB01 Cream 2.0% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 14, 2019
Primary completion
Sep 20, 2022
Completion
Jan 16, 2023
Last update posted
Nov 13, 2024

2019 – 2023

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Ark Clinical Research Long Beach California 90806
Foxhall Dermatology Washington D.C. District of Columbia 20016
Gold Coast Dermatology Delray Beach Florida 33446
Miami Dade Medical Research Institute, LLC Miami Florida 33176
The Dermatology Centre of Indiana Plainfield Indiana 46168
Forefront Dermatology Louisville Kentucky 40202
The Dermatology Clinic Baton Rouge Louisiana 70808
Oakland Hills Dermatology P.C. Auburn Hills Michigan 48326
Associated Skin Care Specialists Fridley Minnesota 55432
JUVA Skin & Laser Center New York New York 10022
UNC Dermatology and Skin Cancer Center Chapel Hill North Carolina 27516
Bexly Dermatology Bexley Ohio 43209
Apex Clinical Research Center, LLC Mayfield Heights Ohio 44124
West Virginia Research Institute Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03680131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03680131 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →